The information can help regulators to decide whether to demand concessions from a company. Businesses and academics have in recent years criticized EU antitrust laws for being inadequate, especially in relation to U.S. tech giants’ merger deals and market power.
Following feedback from more than 100 stakeholders, the EU executive proposed some additions to the rules.
These include greater emphasis on non-price elements such as innovation and quality of products and services and new guidance defining digital markets such as multi-sided markets and digital eco-systems where products are built around a mobile operating system.
For markets expected to undergo structural transitions, such as technological or regulatory changes, the rules will take a forward-looking approach, the Commission said.
There will be need for principles clarifying how markets should be assessed where companies compete on innovation, including through pipeline products. This feature mainly targets pharmaceutical companies.
Interested parties have until January 13 to provide feedback before the Commission finalizes its proposals and adopt the new rules in the third quarter of 2023.
